| | Demographic characteristics | No-AKI () | AKI () | value |
| | Height (cm) | | | 0.026 | | BMI (m/kg2) | | | 0.129 | | APS III | | | <0.001 | | First wardid | 12 (8) | 14 (3) | 0.320 | | Last wardid | 14 (8) | 14 (3) | 0.687 | | LOS | 1.64 (1.49) | 2.39 (3.41) | <0.001 | | Age | | | 0.011 | | Weight | | 1 | 0.010 | | SAPS | | | <0.001 | | SOFA | | | <0.001 | | SAPS II | | | <0.001 | | Elix score | | | 0.098 | | Elixhauser vanwalraven | | | 0.019 | | Elixhauser_sid29 | | | 0.002 | | Elixhauser_sid30 | | | 0.005 | | Mingcs | 15 (1) | 15 (0) | 0.163 | | GCSmotor | 6 (1) | 6 (5) | 0.010 | | GCSverbal | 5 (4.5) | 1.85 (5) | 0.001 | | GCSeyes | 4 (1) | 3 (3) | 0.001 | | GCStotal | 14 (6) | 10 (12) | 0.001 | | Glucosemin (mmol) | | | 0.050 | | Glucosemax (mmol) | | | 0.027 | | Glucosemean (mmol) | | | 0.540 | | Glucoserange (mmol) | | | 0.002 | | HbA1c (%) | | | 0.193 | | HRfirst (bpm) | | | 0.416 | | HRmin (bpm) | | | 0.602 | | HRmax (bpm) | | | <0.001 | | CVPfirst (cmH2O) | | | 0.082 | | CVPmin (cmH2O) | | | 0.266 | | MAPfirst (mmHg) | | | 0.006 | | MAPmin (mmHg) | | | <0.001 | | MAPmax (mmHg) | | | <0.001 | | Temperaturefirst (°C) | | | 0.013 | | Temperaturemin (°C) | | | 0.006 | | Temperaturemax (°C) | | | 0.392 | | Hemoglobinfirst (g/L) | | | 0.064 | | Hemoglobinmin (g/L) | | | <0.001 | | Hemoglobinmax (g/L) | | | 0.475 | | WBCfirst (×10^9/L) | | | 0.063 | | WBCmin (×10^9/L) | | | 0.036 | | WBCmax (×10^9/L) | | | 0.005 | | PLTfirst (×10^9/L) | | | 0.016 | | PLTmin (×10^9/L) | | | 0.007 | | PLTmax (×10^9/L) | | | 0.235 | | Angus sepsis, (%) | 12 (10) | 83 (19) | 0.029 | | Sedative, (%) | 51 (42) | 307 (70) | <0.001 | | Gender, (%) | 69 (57) | 299 (68) | 0.033 | | SIRS | | | 0.005 | | 0 | 3 (2) | 3 (1) | | | 1 | 21 (17) | 32 (7) | | | 2 | 31 (26) | 107 (24) | | | 3 | 37 (31) | 165 (38) | | | 4 | 29 (24) | 133 (30) | | | Ventilation, (%) | 54 (45) | 327 (74) | <0.001 | | Vasoactive drugs, (%) | 43 (36) | 264 (60) | <0.001 | | Congestive heart failure, (%) | 3 (2) | 25 (6) | 0.231 | | Cardiac arrhythmias, (%) | 5 (4) | 29 (7) | 0.430 | | Valvular disease, (%) | 1 (1) | 10 (2) | 0.471 | | Pulmonary circulation, (%) | 2 (2) | 4 (1) | 0.614 | | Peripheral vascular, (%) | 14 (12) | 56 (13) | 0.853 | | Hypertension, (%) | 6 (5) | 57 (13) | 0.021 | | Paralysis, (%) | 4 (3) | 8 (2) | 0.299 | | Other neurological, (%) | 4 (3) | 20 (5) | 0.731 | | Chronic pulmonary, (%) | 14 (12) | 71 (16) | 0.272 | | Uncomplicated diabetes, (%) | 25 (21) | 128 (29) | 0.084 | | Complicated diabetes, (%) | 3 (2) | 21 (5) | 0.395 | | All diabetes, (%) | 28 (23) | 149 (34) | 0.033 | | CHF, (%) | 28 (23) | 141 (32) | 0.075 | | Atrial fibrillation, (%) | 25 (21) | 154 (35) | 0.004 | | Renal disease, (%) | 9 (7) | 47 (11) | 0.377 | | COPD, (%) | 7 (6) | 43 (10) | 0.237 | | CAD, (%) | 64 (53) | 276 (63) | 0.063 | | Stroke, (%) | 10 (8) | 26 (6) | 0.467 | | Malignancy, (%) | 10 (8) | 39 (9) | 0.980 | | Cardiopulmonary bypass, (%) | 36 (30) | 259 (59) | <0.001 | | CABG, (%) | 17 (14) | 207 (47) | <0.001 | | Left heart catheterization, (%) | 54 (45) | 159 (36) | 0.110 |
|
|